Chelsie Macedo

Title: Chelsie Macedo: Innovator in OX40 and 41BB-Binding Proteins

Introduction

Chelsie Macedo is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of biotechnology, particularly in the development of innovative molecules that engage specific receptors in the immune system. With a total of five patents to her name, her work is paving the way for advancements in therapeutic applications.

Latest Patents

Among her latest patents, Chelsie has developed multivalent and multispecific OX40-binding fusion proteins. This invention focuses on molecules that specifically engage OX40, a member of the TNF receptor superfamily. More specifically, it relates to multivalent and multispecific molecules that bind at least OX40. Additionally, she has created multivalent and multispecific 41BB-binding proteins, which similarly engage 41BB, another member of the TNF receptor superfamily. This invention also emphasizes the development of multivalent and multispecific molecules that bind at least 41BB.

Career Highlights

Chelsie has worked with notable companies in the biotechnology sector, including Inhibrx, Inc. and Inhibrx Biosciences, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.

Collaborations

Some of her coworkers include Brendan P Eckelman and John C Timmer. Their collaborative efforts have contributed to the success of her innovative projects.

Conclusion

Chelsie Macedo is a trailblazer in the field of biotechnology, with her patents focusing on critical immune system receptors. Her work continues to influence the development of new therapeutic strategies.